| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/02/2001 | EP1094790A1 Sustained release pharmaceutical preparation |
| 05/02/2001 | EP1094787A1 Preparations for protecting infants' skin against diaper dermatitis |
| 05/02/2001 | EP1094712A1 Hypericin and hypericum extract: specific t-type calcium channel blocker, and their use as t-type calcium channel targeted therapeutics |
| 05/02/2001 | EP1094711A1 Methods for eradication of nanobacteria |
| 05/02/2001 | EP1071329A4 Methods and compositions for treatment of aids-associated kaposi's sarcoma |
| 05/02/2001 | EP0988304B1 Nucleosides analogues, such as antivirals including inhibitors of retroviral reverse transcriptase and the dna polymerase of hepatitis b virus (hbv) |
| 05/02/2001 | EP0984959A4 Aromatic sulfonyl alpha-hydroxy hydroxamic acid compounds |
| 05/02/2001 | EP0983257A4 Aromatic sulfonyl alpha-cycloamino hydroxamic acid compounds |
| 05/02/2001 | EP0973392A4 Sulfonyl divalent aryl or heteroaryl hydroxamic acid compounds |
| 05/02/2001 | EP0966427B1 Preparation of acid amides and metallisation of compounds |
| 05/02/2001 | EP0938318B1 Tablet with controlled release of alfuzosine chlorydrate |
| 05/02/2001 | EP0885218B1 Oxa- and thia-diazole muscarinic receptor antagonists |
| 05/02/2001 | EP0882010B1 Pharmaceutical agents containing perfluoroalkyl-containing metal complexes and the use thereof in tumour therapy and interventional radiology |
| 05/02/2001 | EP0863866B1 Butyrate prodrugs of lactic acid |
| 05/02/2001 | EP0778820B1 Neurotrophic and antiproliferative compounds |
| 05/02/2001 | EP0769947B1 Indolinone compounds for the treatment of disease |
| 05/02/2001 | EP0750502B1 Use of phosphorus derivatives of alkaloids for treating endocrinopathies |
| 05/02/2001 | EP0743853B1 Compounds active at a novel site on receptor-operated calcium channels useful for treatment of neurological disorders and diseases |
| 05/02/2001 | CN1293679A New pentasaccharides, their methods of production and pharmaceutical compositions containing same |
| 05/02/2001 | CN1293674A Triazolo gerivatives and chemokine inhibitors containing the same as the active ingredient |
| 05/02/2001 | CN1293673A 1-(3-heteroarylpropyl-or-prop-2-enyl)-4-benzylpiperidines used as NMDA receptor antagonists |
| 05/02/2001 | CN1293671A Substituted bisindolymaleimides for inhibition of cell proliferation |
| 05/02/2001 | CN1293669A Benzylpiperazingl-and benzylipeeridinyl ethanone derivatives, their preparation method and their use as dopamine D receptor antagonists |
| 05/02/2001 | CN1293666A Benzenesulfonamide-derivatives and their use as medicaments |
| 05/02/2001 | CN1293665A New compounds and their use as positive AMPA receptor modulators |
| 05/02/2001 | CN1293664A Cyclooctadepsipeptides and their use for combating endoparasites |
| 05/02/2001 | CN1293663A 2,3,4,5-tetrahydro-1H-[1,4] benzodiazepine-3-hydroxamix acids as matrix metal-protease |
| 05/02/2001 | CN1293662A Novel sulfonamide derivatives as inhibitors of bone resorption and as inhibitors of cell adhesion |
| 05/02/2001 | CN1293661A Pyridazinone hydrochloride compound and method for producing the same |
| 05/02/2001 | CN1293659A New compounds |
| 05/02/2001 | CN1293656A Anti-tumour agents |
| 05/02/2001 | CN1293655A Bicyclo [2.2.1] heptanes and related compounds |
| 05/02/2001 | CN1293654A Anti-tumour agents |
| 05/02/2001 | CN1293575A Utilization of extracts from iris plants, cimicifuga racemosa and tectorigenin as estrofen-like organ-selective medicament without uteroetropic effects |
| 05/02/2001 | CN1293573A Methods of treating tardive dyskinesia and other movement disorders |
| 05/02/2001 | CN1293572A Method and means for treating glomerulonephritis |
| 05/02/2001 | CN1293571A Extended release tiagabine formulations with reduced side-effects |
| 05/02/2001 | CN1293570A Pharmaceutical formulations for taxanes |
| 05/02/2001 | CN1293569A New treatments for nervous disorders |
| 05/02/2001 | CN1293565A Compositions for regulating skin appearance |
| 05/02/2001 | CN1293564A Method for regulating skin apperance |
| 05/02/2001 | CN1293562A Method of reducing cellulite in mammalian skin |
| 05/02/2001 | CN1293543A Method for producing fat mixture |
| 05/02/2001 | CN1293196A Dibenzylisoquinoline alkaloids and its preparing process and medicinal composition |
| 05/02/2001 | CN1293195A New polycyclicazaindole compound, its preparation method are medicine composition containing same |
| 05/02/2001 | CN1293194A New 7-amino pyrido[2,3-d] pyrimidine derivative |
| 05/02/2001 | CN1293193A Preparation of piperidyl amino methyl trifluoro methyl cyclo other compounds |
| 05/02/2001 | CN1293192A New benzothiophene, benzofuran and indole compounds, preparation method therefor and medicine composition containing same |
| 05/02/2001 | CN1293067A Use of 4-(4-ethoxybenzyl)-3,6,9-tri(carboxymethyl)-3,6,9-triazohendecanedioic acid calcium composition |
| 05/02/2001 | CN1293049A 'Shexingkeyu' capsule for treating cardiovascular and cerebrovascular diseases and its preparing process |
| 05/02/2001 | CN1293040A Amino acid gelatin pill |
| 05/02/2001 | CN1293039A 氨基酸胶囊 Amino acid capsules |
| 05/02/2001 | CN1293038A Composition for preparing medicines, beautifying and cosmetics and its application |
| 05/02/2001 | CN1293037A Long-acting erythrocin injection |
| 05/02/2001 | CN1293036A Use of 4-(4-ethoxygenzyl)-3,6,9-tri(carboxymethyl)-3,6,9-triazohendecanedioic acid calcium composition |
| 05/02/2001 | CN1065277C Process for preparation of avermectins |
| 05/02/2001 | CN1065246C Process for preparation of salt of clavulanic acid |
| 05/02/2001 | CN1065244C Tricyclic benzazepine vasopressin antagonists |
| 05/02/2001 | CN1065240C Taxanes having butenyl substituted side-chain and pharmaceutical compositions containing them |
| 05/02/2001 | CN1065238C Intermediate compound suitable for synthesing modified oligodeoxynucleotide acid |
| 05/02/2001 | CN1065237C Cyclopentane-and-cyclo pentene-beta-amino acids |
| 05/02/2001 | CN1065140C synergistic therapeutic composition and methods |
| 05/02/2001 | CN1065128C Amino acid metal chelate preparation and preparaing method |
| 05/02/2001 | CN1065110C Colloidally disperson agent of active compount |
| 05/01/2001 | US6225501 Optically active 2-aminotetraline, process for its preparation and pharmaceutical compositions containing same, active in preventing and treating septic shock |
| 05/01/2001 | US6225494 Trisubstituted phenyl derivatives having retinoid agonist or inverse agonist type biological activity |
| 05/01/2001 | US6225486 Composition comprising mixture of free fatty acid conjugated linoleic acid isomers containing at least approximately 92 per cent trans 10, cis 12-octadecadienoic acid |
| 05/01/2001 | US6225481 Robustaflavone, intermediates and analogues and method for preparation thereof |
| 05/01/2001 | US6225457 Polynucleotide sequences associated with bacterial proteins; for detection of bactericides |
| 05/01/2001 | US6225452 Ampilfying reproduction in humans; administer tagatose to mammals and monitor reproductive activity |
| 05/01/2001 | US6225445 Fatty acid derivatives of sulfhydryl-containing compounds (for example, sulfhydryl-containing peptides or proteins) comprising fatty acid-conjugated products with a disulfide linkage |
| 05/01/2001 | US6225356 Cromolyn sodium containing composition and method of treatment for vilvar vestibulitis interstitial cystitis vukvar vaginitis and vaginitis dynea |
| 05/01/2001 | US6225355 Process for removing bile salts from a patient and alkylated compositions therefor |
| 05/01/2001 | US6225354 Subjecting unsaponified beeswax to liquid extraction with liquid organic extractant in which primary aliphatic alcohols are soluble; recovering alcohol mixture and isolating alcohols |
| 05/01/2001 | US6225353 Method and composition for selectively inhibiting melanoma |
| 05/01/2001 | US6225351 For therapy of asthma, arthritis, and sepsis bronchitis, chronic obstructive airways disease, psoriasis, allergic rhinitis, dermatitis, sepsis, septic shock, cachexia, acquire immuno deficiency syndrome (aids) |
| 05/01/2001 | US6225350 Butyrate prodrugs derived from lactic acid |
| 05/01/2001 | US6225348 Contacting eye with prostaglandin f.sub.2.alpha. derivative for therapy of macular degeneration in an eye |
| 05/01/2001 | US6225347 For lowering blood pressure, inhibiting platelet aggregation, for luteolytic effect, healing ulcer, inhibiting gastric acid secretion, as cytoprotective agent |
| 05/01/2001 | US6225345 Azahexane derivatives as substrate isosters of retroviral asparate proteases |
| 05/01/2001 | US6225343 Compositions and methods comprising morphine gluconate |
| 05/01/2001 | US6225342 Use of calendula glycosides for the treatment of psoriasis |
| 05/01/2001 | US6225341 For inhibiting neuraminidase; for therapy and prophylaxis of virus infection |
| 05/01/2001 | US6225340 Administering a dosage comprising 5-amino-2,2-dimethyl-6-(3'-(r,s) amino-4'-hydroxy-butan-1-one)-2,3-dihydro-4h-1-benzopyran-4-on e with carrier to inhibit arthritis |
| 05/01/2001 | US6225339 Terpenoid lactone compounds and their production process |
| 05/01/2001 | US6225338 As antineoplastic agents and antioxidants |
| 05/01/2001 | US6225335 3-(4′-bromobenzylindenyl)-2-indolinone and analogues thereof for the treatment of disease |
| 05/01/2001 | US6225333 Method of treatment of pigmented cancer cells utilizing photodynamic therapy |
| 05/01/2001 | US6225332 Topically administering histamine h.sub.2 agonist(s) for therapy of ocular allergy and inflammation |
| 05/01/2001 | US6225331 For therapy and prophylaxis nasal congestion, otitis media, and sinusitis, treating cough, chronic obstructive pulmonary disease (copd) and/or asthma, benign prostatic hypertrophy, cardiovascular disorders, glaucoma, hyperemia, conjunctivitis |
| 05/01/2001 | US6225328 Adamantyl-substituted retinoids and pharmaceutical/cosmetic compositions comprised thereof |
| 05/01/2001 | US6225327 Topically administering dihydropyridine compound which is human conjunctival mast cell stabilizer for alleviating ocular allergic reactions involving conjunctival mast cell degranulation |
| 05/01/2001 | US6225326 Administering insulin sensitivity enhancer in combination with an .alpha.-glucosidase inhibitor for therapy to reduce side effect for diabetic patient |
| 05/01/2001 | US6225325 Administering n-substituted-1,5-dideoxy-1,5-imino-d-glucitol or galactitol for prophylaxis, therapy, reducing, or reversing multidrug resistance in patient undergoing therapy with chemotherapeutic agent |
| 05/01/2001 | US6225324 Antidepressant heterocyclic compounds |
| 05/01/2001 | US6225323 Activated iododerivatives for the treatment of cancer and AIDS |
| 05/01/2001 | US6225320 Treatment of pain, inflammation, migraine, emesis and posttherpetic neuralgia |
| 05/01/2001 | US6225316 3-phenyl-pyridine-derivatives |
| 05/01/2001 | US6225315 Administering a cgmp pde inhibitor. |
| 05/01/2001 | US6225314 Inhibition of matrix metalloproteases by substituted biaryl oxobutyric acids |